|
|
|
|
|
|
by bookofjoe
450 days ago
|
|
|
>Well there’s your problem: no one can make money off of it, unless they develop a new delivery mechanism, etc. You hit the nail on the head. Ketamine is a generic drug that costs next to nothing; Spravoto (ketamine-derived nasal spray) is already a billion dollar/year drug for Johnson & Johnson, with prospects of $5 billion/year. Source: https://archive.ph/rzqxt [Wall Street Journal] |
|
|